I am an independent Medicare broker in the upper Midwest, and every fall I spend long afternoons at kitchen tables with retirees who already know the basics and just want the plain truth. I look at plan grids, drug lists, network maps, and the small print that usually gets skipped until a claim goes sideways. For Aetna’s 2027 Medicare Advantage plans, I would approach the year as a serious planning exercise rather than a finished shopping season. That sounds cautious, because it is.

Why I am treating 2027 as a planning year, not a finished product

As of April 20, 2026, CMS has already published the 2027 Advance Notice and the final 2027 Rate Announcement, which tells me the federal payment and policy framework is moving. That still does not give me the county level Summary of Benefits that a real shopper needs before enrolling. On the public side, Aetna’s Medicare shopping pages I can see are still centered on 2026 plans and general plan types, so I read that as a sign that the 2027 member-facing details are not broadly posted yet. I would not pretend those are the same thing.

That distinction matters more than most people expect. A federal rate announcement can shape pricing pressure, plan design pressure, and how insurers think about bids, but it does not tell me whether my client’s cardiologist will still be in network in her county or whether a Tier 3 brand drug moved to a tougher cost share. I have learned to slow people down right there, because a lot of bad enrollments start with someone assuming a company announcement means their exact local plan is already settled. County details rule.

I have had more than one client tell me in late spring that they want to “lock in” next year early, and I always push back. I would rather spend 20 minutes building a watch list than rush into a guess based on old documents. A customer last spring brought me a neatly highlighted packet from the prior year, and half of what she cared about had changed by the time enrollment arrived. That memory stays with me.

How I research Aetna before the final county details land

I start by gathering every public clue I can find, but I keep each clue in its place. For people who want one place to compare plan snapshots before every official filing is easy to find, I sometimes point them to Aetna 2027 Medicare Advantage plans as a research starting point, then I tell them to verify every benefit against Aetna’s own plan documents before making a decision. I never treat a comparison page as the last word. I treat it like a notebook.

After that, I wait for the documents that actually settle arguments. On Aetna’s Medicare site, the public plan pages already show the kind of materials I care about each year, especially the Summary of Benefits and the Annual Notice of Change, because those are where costs, copays, and coverage terms stop being fuzzy. If I cannot put my finger on those documents for the exact plan and county, I assume I am still in the preview stage. That part is simple.

I also check quality signals, but I keep them in proportion. Aetna said that for 2026, more than 81 percent of its Medicare Advantage members were in plans rated 4 stars or higher, and more than 63 percent were in 4.5 star plans, which is a useful sign that the company has strong performers in the book. I still do not let a star rating overrule a bad formulary match or a missing hospital system. A shiny score can hide a clumsy fit.

The spots where I see people choose the wrong plan

The first trouble spot is usually provider access. Aetna’s current public materials say its PPO plans let members see providers in or out of network who accept the plan terms, while its HMO-POS plans lean more heavily on network use for medical care, with some limited extra flexibility in areas like dental. I read those differences closely because two plans can look similar on a flyer and feel very different once specialist visits start stacking up. I have watched that misunderstanding cost people months of frustration.

The second trouble spot is the drug list, and I am blunt about that because I have seen too many surprises. I do not care how attractive the dental allowance looks if a client’s three maintenance drugs move to a pricier tier, need prior authorization, or stop working with the pharmacy they have used for 12 years. A plan can feel affordable in October and feel expensive by February if the drug coverage is off by even a little. That is why I mark prescriptions before perks.

The third trouble spot is scale. CVS Health said Aetna’s 2026 Medicare Advantage Prescription Drug offerings would be available in 43 states plus Washington, D.C., accessible to 57 million Medicare eligible people, and that sounds enormous because it is. Still, broad reach does not mean your county gets the same network, the same copays, or the same extra benefits as the county next door, and I never let brand size trick me into assuming local sameness. Bigger is not simpler.

I also tell clients not to fall in love with extras before they price the boring stuff. A hearing allowance, an over the counter card, or a fitness benefit can all be useful, and I like seeing those benefits when they truly fit the person in front of me. Yet I would trade a flashy add-on for a better hospital network or a more predictable specialist copay almost every time. That is not glamorous advice, but it holds up.

Dates decide more than brand names

Most enrollment mistakes I clean up are really calendar mistakes. Medicare’s main Open Enrollment runs from October 15 through December 7, and changes made then generally take effect January 1, which means the real comparison work has to happen before holiday distractions take over. I tell people to start their review early, because waiting until the first week of December usually turns a careful decision into a rushed one. Dates decide everything.

I also remind existing Medicare Advantage members that there is a separate Medicare Advantage Open Enrollment Period from January 1 through March 31. During that window, someone already in a Medicare Advantage plan can make one change by switching to another Medicare Advantage plan or by returning to Original Medicare and, if needed, joining a stand-alone drug plan. I have used that window to fix bad fits more than once, but I still prefer getting it right in the fall because cleanup work is stressful and sometimes limited by the choices left on the table.

For Aetna in 2027, my own process would be steady and boring in the best possible way. I would watch for the county specific Summary of Benefits, compare the provider directory against the doctors a client actually uses, run every regular prescription through the formulary, and check whether the annual out of pocket limit still feels safe for that person’s medical pattern. Then I would read the Annual Notice of Change line by line, even if the client swears nothing important ever changes. Something usually does.

If I were helping a neighbor sort through Aetna’s 2027 Medicare Advantage options, I would tell them to stay interested but stay skeptical until the local documents are live. I would rather have a person bring me a marked-up plan packet in October than a denial notice in February. The right Aetna plan could be a very good fit in one county and a weak fit in the next, and I have learned to respect that difference every single year. My best advice is still the oldest advice I give: slow down, read the evidence, and choose the plan that fits your real life instead of the one that sounds nicest on first pass.